BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 33542222)

  • 21. In vitro and in vivo anti-tumour effects of MPT0B014, a novel derivative aroylquinoline, and in combination with erlotinib in human non-small-cell lung cancer cells.
    Tsai AC; Pai HC; Wang CY; Liou JP; Teng CM; Wang JC; Pan SL
    Br J Pharmacol; 2014 Jan; 171(1):122-33. PubMed ID: 24116948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation.
    Guan Z; Chen J; Li X; Dong N
    Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32776119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro and in vivo characterization of a benzofuran derivative, a potential anticancer agent, as a novel Aurora B kinase inhibitor.
    Xie F; Zhu H; Zhang H; Lang Q; Tang L; Huang Q; Yu L
    Eur J Med Chem; 2015 Jan; 89():310-9. PubMed ID: 25462247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiation Enhancement of Head and Neck Squamous Cell Carcinoma by the Dual PI3K/mTOR Inhibitor PF-05212384.
    Leiker AJ; DeGraff W; Choudhuri R; Sowers AL; Thetford A; Cook JA; Van Waes C; Mitchell JB
    Clin Cancer Res; 2015 Jun; 21(12):2792-801. PubMed ID: 25724523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plant-derived flavones as inhibitors of aurora B kinase and their quantitative structure-activity relationships.
    Jung Y; Shin SY; Yong Y; Jung H; Ahn S; Lee YH; Lim Y
    Chem Biol Drug Des; 2015 May; 85(5):574-85. PubMed ID: 25298094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of RIPK1 and FADD are associated with chemosensitivity and survival in head and heck squamous cell carcinoma via tanshinone IIA-mediated modulation of the RIPK1-FADD-Caspase 8 complex.
    Shen B; Han W; Tan X; Gu KJ; Naseem DF; Zheng G; Li G; Lou J; Chen C
    Mol Carcinog; 2024 Jul; 63(7):1406-1416. PubMed ID: 38695620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
    Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Barasertib (AZD1152), a Small Molecule Aurora B Inhibitor, Inhibits the Growth of SCLC Cell Lines In Vitro and In Vivo.
    Helfrich BA; Kim J; Gao D; Chan DC; Zhang Z; Tan AC; Bunn PA
    Mol Cancer Ther; 2016 Oct; 15(10):2314-2322. PubMed ID: 27496133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new small-molecule Aurora B inhibitor shows antitumor activity in human cancer cell lines.
    Wu Y; Li J; Jiang C; Yang X; Cao L; Yu L
    Mol Biol Rep; 2015 Feb; 42(2):517-24. PubMed ID: 25348602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3,6,2',4',5'-Pentahydroxyflavone, an orally bioavailable multiple protein kinase inhibitor, overcomes gefitinib resistance in non-small cell lung cancer.
    Sheng Y; Li W; Zhu F; Liu K; Chen H; Yao K; Reddy K; Lim DY; Oi N; Li H; Peng C; Ma WY; Bode AM; Dong Z; Dong Z
    J Biol Chem; 2014 Oct; 289(41):28192-201. PubMed ID: 25122774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cordycepin Enhances Radiosensitivity in Oral Squamous Carcinoma Cells by Inducing Autophagy and Apoptosis Through Cell Cycle Arrest.
    Ho SY; Wu WS; Lin LC; Wu YH; Chiu HW; Yeh YL; Huang BM; Wang YJ
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antitumor Activity of KW-2450 against Triple-Negative Breast Cancer by Inhibiting Aurora A and B Kinases.
    Kai K; Kondo K; Wang X; Xie X; Pitner MK; Reyes ME; Torres-Adorno AM; Masuda H; Hortobagyi GN; Bartholomeusz C; Saya H; Tripathy D; Sen S; Ueno NT
    Mol Cancer Ther; 2015 Dec; 14(12):2687-99. PubMed ID: 26443806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioactive compounds of Eriocaulon sieboldianum blocking proliferation and inducing apoptosis of HepG2 cells might be involved in Aurora kinase inhibition.
    Fan Y; Lu H; Ma H; Feng F; Hu X; Zhang Q; Wang J; Xu Y; Zhao Q
    Food Funct; 2015 Dec; 6(12):3746-59. PubMed ID: 26369427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CS2164, a novel multi-target inhibitor against tumor angiogenesis, mitosis and chronic inflammation with anti-tumor potency.
    Zhou Y; Shan S; Li ZB; Xin LJ; Pan DS; Yang QJ; Liu YP; Yue XP; Liu XR; Gao JZ; Zhang JW; Ning ZQ; Lu XP
    Cancer Sci; 2017 Mar; 108(3):469-477. PubMed ID: 28004478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endoplasmic reticulum stress sensitizes human esophageal cancer cell to radiation.
    Pang XL; He G; Liu YB; Wang Y; Zhang B
    World J Gastroenterol; 2013 Mar; 19(11):1736-48. PubMed ID: 23555162
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Licochalcone D directly targets JAK2 to induced apoptosis in human oral squamous cell carcinoma.
    Seo JH; Choi HW; Oh HN; Lee MH; Kim E; Yoon G; Cho SS; Park SM; Cho YS; Chae JI; Shim JH
    J Cell Physiol; 2019 Feb; 234(2):1780-1793. PubMed ID: 30070696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic targeting of Polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblastic leukemia.
    Spartà AM; Bressanin D; Chiarini F; Lonetti A; Cappellini A; Evangelisti C; Evangelisti C; Melchionda F; Pession A; Bertaina A; Locatelli F; McCubrey JA; Martelli AM
    Cell Cycle; 2014; 13(14):2237-47. PubMed ID: 24874015
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Daurinol Enhances the Efficacy of Radiotherapy in Lung Cancer via Suppression of Aurora Kinase A/B Expression.
    Woo JK; Kang JH; Shin D; Park SH; Kang K; Nho CW; Seong JK; Lee SJ; Oh SH
    Mol Cancer Ther; 2015 Jul; 14(7):1693-704. PubMed ID: 25882311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aurora kinases as targets in drug-resistant neuroblastoma cells.
    Michaelis M; Selt F; Rothweiler F; Löschmann N; Nüsse B; Dirks WG; Zehner R; Cinatl J
    PLoS One; 2014; 9(9):e108758. PubMed ID: 25268132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.